Replies to post #331698 on Anavex Life Sciences Corp (AVXL)

[LBSR TO DA MOON]

The company that Green is talking about is definitely not AVXL.
He states during the interview that the company received Orphan Drug Designation for A1AC Deficiency (I ran a database search but came up with nothing) and that they have multiple deals set up with Eli Lilly, Roche and Novo Nordisk. He also states that Wellington Management Group has invested $107M in the company and that the stock is around $25 or so. Maybe someone with premium access to Fintel or Whale Wisdom can go in and research their holdings in order to determine the ticker of the company in question...

Here is a link to an interview of Alexander Green where he states
"“There’s going to be more wealth created in the next two years (of the Biden Presidency)… than the past 20 years combined.”
https://links.thebreadwinner.co/a/1496/click/343/66234/9887187500f72766c758d2efddbc4f4fd4ae6e5a/e391ee1e0270caedddffafd8db9a57543f673203
More importantly he talks about a small biotech company that has about 25 employees and has about 250 worldwide patents that is going to likely solve most diseases using mRNA technique. He doesn't reveal the name during the interview.
He also states that the company has commitments of billions of dollars from Eli Lilly and a few others. A lot of it sounded to me to be very similar to AVXL or a possible competitor.
The mRNA portion starts at approximately the 52 minute mark of the interview.
If someone can take the time to listen to this and has much knowledge on this, I would appreciate your opinion.